The Native Antigen Company

At the Native Antigen Company we are experts in the development and manufacturing of infectious disease antigens from bacteria and viruses, and in the production of recombinant forms of these antigens using our proprietary mammalian expression system. These antigens are prepared for both research and development purposes, and also on bulk scale for IVD manufacturers to incorporate into their immunoassays. Our R&D team have particular expertise in flavivirus biology. We were the first in the world to develop mammalian expressed Dengue virus NS1 antigens, and then to develop Zika virus NS1 using the same platform. We have also developed a...

Infectious disease antigens,contract research,protein purification,contract development,zika virus r&d,mammalian recombinant protein expression,immunoassay development,monoclonal antibodies,and dengue virus

The native antigen company operates in the Biotechnology research industry.

The native antigen company's revenue is 11m - 100m

The native antigen company has 11 - 50 employees.